Strategic Partnerships Leverage historical partnership with Princeton University and recent Massachusetts CRO/CMO symposium attendance to position HepatoChem as a collaborator for contract research, manufacturing, and photoreactor/metabolite solutions; target CROs, CMOs, and university-affiliated labs for joint development and pilot programs.

Capable Scale Despite a small team, HepatoChem has a demonstrated revenue range of 10–25 million and a focused niche in photoreactors, metabolites, and LEDs, suggesting opportunities for scalable collaboration with mid-market pharma manufacturers and specialty chemical producers seeking novel photochemical capabilities.

Innovation Spotlight Emphasize the company’s long-standing position since 2008 as an innovator in photoreactors and LEDs to attract customers needing advanced photochemical processes, photoreactor customization, and rapid prototyping for early-stage drug discovery or metabolite synthesis.

Global Visibility Strengthen outreach through the company’s web presence and tech stack signals (SEO, analytics, and modern web practices) to improve inbound inquiries from researchers and potential distributors; propose channel partnerships and regional reps to extend market reach.

Financial Fit With modest funding and solid revenue, target HepatoChem for value-based deals, ongoing service contracts, and volume-based pricing for photoreactor consumables, maintenance, and retrofit projects aligned with potential growth funding rounds.